What is the next earnings date for STAB stock?
STATERA BIOPHARMA INC (STAB) will report earnings on 2023-03-29.
STATERA BIOPHARMA INC (STAB) Forecast, Price Target & Analyst Ratings
NASDAQ:STAB • US8575611046
Current stock price
0.0911 USD
-0.01 (-5.2%)
At close:
0.0918 USD
+0 (+0.77%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for STATERA BIOPHARMA INC (STAB).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$0.00
Upside
-100.00%
From current price of $0.09 to mean target of $0.00, Based on 0 analyst forecasts
Low
$0.00
Median
$0.00
High
$0.00
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
0.00%
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 29, 2023
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2019 | 2020 | 2021 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 1.113M -2.18% | 262.94K -76.38% | 1.487M 465.54% | |
| EBITDA YoY % growth | -2.347M 50.92% | -2.575M -9.72% | -29.687M -1,052.86% | |
| EBIT YoY % growth | -2.361M 50.81% | -2.587M -9.56% | -29.943M -1,057.64% | |
| Operating Margin | -212.03% | -983.70% | -2,013.59% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A